Jeewan Jyoti Medical Society has confirmed that it, along with persons acting in concert, did not create any encumbrance on shares of Zuari Industries Limited during the financial year ended March 31, 2026. This disclosure ensures that no new liens or charges were placed on the holdings outside of those previously reported to the stock exchanges and the company.

The declaration was submitted to the Audit Committee of Zuari Industries Limited, the National Stock Exchange Limited, and BSE Limited. It was made in compliance with Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.

The communication, dated April 2, 2026, serves as a formal confirmation for the records of the company and the regulatory authorities. It explicitly states that the absence of encumbrance applies both directly and indirectly to the shares held by the society and its concert parties.

Zuari Industries returned to profitability in FY26, reporting a consolidated net profit of ₹105.8 crore against a net loss of ₹94.4 crore in the previous year. The turnaround was driven by improved operational efficiencies, financial discipline, and a reduction in borrowing costs. The Board of Directors, meeting on May 25, 2026, approved the audited standalone and consolidated financial results and recommended a final dividend of ₹1 per equity share. The company filed a revised investor presentation with exchanges on May 26, 2026, superseding the previous day's submission. Additionally, the company confirmed that newspaper publications for the audited financial results were released on May 26, 2026, in Business Standard and Lokmat, pursuant to Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The statutory auditors, V. Sankar Aiyar & Co., issued an unmodified opinion on the audited financial results.

Q4 Performance

Zuari Industries reported notable quarterly momentum, with Q4 EBITDA rising to ₹423 million compared to ₹276 million in the same period last year, reflecting a significant improvement in operational profitability. The Q4 EBITDA margin expanded to 14.93% from 10.14% year-on-year, underscoring improved cost efficiencies. Q4 consolidated revenue grew to ₹2.83 billion from ₹2.7 billion year-on-year. However, the company reported a Q4 consolidated net loss of ₹316 million, widening from a net loss of ₹207 million in the corresponding period of the previous year.

The key Q4 metrics are summarised below:

Full Year Financial Performance

For the full year, the company posted a consolidated total income of ₹1,155.1 crore, up from ₹1,082.5 crore in FY25. Consolidated EBITDA rose 12.20% year-on-year to ₹181.0 crore. On a standalone basis, Zuari Industries reported a net profit of ₹12.1 crore for the year, recovering from a net loss of ₹37.4 crore in FY25. Standalone EBITDA increased 6.80% to ₹191.5 crore, while total income rose to ₹994.9 crore from ₹979.9 crore.

Operational Highlights

The Sugar, Power & Ethanol (SPE) division delivered strong operational performance, achieving its highest-ever seasonal crush of 163.7 lakh quintals. Total cane crush for FY26 stood at 159.7 lakh quintals as against 157.2 lakh quintals in FY25. Ethanol production increased by 10.10% year-on-year to 37,276 KL. Zuari Infraworld India Limited's real estate project, The St. Regis Residences in Dubai, achieved approximately 98% completion, with handovers scheduled from June 2026. Simon India Limited strengthened its execution capabilities, with EBITDA improving to ₹6.8 crore compared to ₹0.9 crore in FY25.

Dividend and Appointments

The Board recommended a final dividend of ₹1 per equity share of ₹10 each, subject to shareholder approval at the upcoming Annual General Meeting. Directors approved the re-appointment of Mr. Alok Saxena (DIN: 08640419) as Whole Time Director and Key Managerial Personnel designated as Executive Director for a period of two years, effective from July 1, 2026, to June 30, 2028.